NLARx Newsletter Header
NLARx News
December 9, 2009
In This Issue
NLARx News
In the States
Outrage of the Week
Health Reform
Prices & Access
Fraud & Abuse
Conflicts of Interest
Patents & Generics
Reimportation
Advertising & Marketing
Pharma Watch
PBM Watch
Medicare & Medicaid
Safety & Clinical Trials
Electronic Records
Privacy
Foreign Countries
In Memoriam
Quick Links
Join Our Mailing List
NLARx in the News
NLARx Joins Letter Supporting Ban on Pay-for-Delay Settlements in Health Reform More
Patient Advocates Ill at Ease with Rx Data Mining More
In the States
NEW JERSEY: Tighter Controls Recommended to Prevent Conflicts of Interest More
AG Wants Pharma-Marketing Crackdown More
Expired Pill Roundup a Success: Should Be a Routine More
MISSISSIPPI: Lilly Wins Zyprexa Case Against State More
MICHIGAN: Preemption Blocking Product Lawsuit Against Novartis More
MAINE: Lawmakers Redraw Bill Aimed at Online Protection of Minors More
OREGON: Aventis Settles on Medicaid Fraud Charges More
Outrage of the Week
Merck Lawyers Concede Vioxx Fraud In 2001 More
Pharmaceuticals and Health Reform
Senate May Not Hold to $80 Billion Pharma Deal More
Deals On Health Reform In Jeopardy More
Allergan, Medicis Lobby Hard Against 'Botax' More
Congress Ups the Pharma Ante More
Prices and Access to Health Care
Pharma Faces More Scrutiny on Drug Prices More
Introducing the $30,000 Per Month Cancer Drug More
Questioning a $30,000-a-Month Cancer Drug More
Drug Makers Play Shell Game With Costs More
Fraud and Abuse
J&J May Face Indictment for Off-Label Marketing of Natrecor More
Marketing Tactics Put Johnson & Johnson Under DOJ Microscope More
Big Pharma's Crime Spree More
Supremes Wary of Merck's Vioxx Arguments More
Conflicts of Interest
Grassley Asks AMA, Other Groups for Data on Industry Payments More
Charting Relationships Between Academics And Industry More
University Ethics Panel Has Conflicted Members More
Yale Issues Faculty Reminder About Ghostwriting More
Clinical Trials, Doctors And Conflicts Of Interest More
Pfizer Funds Canadian CME, Prompting Outcry More
Canada's Medical Association Chided For Pfizer CME Funds More
NJ AG: Clampdown On Pharma Influence On Docs More
No Free Lunch for Doctors, Brought to You By Jersey's AG More
Patents and Generics
Amgen and Teva in Biosimilar Neupogen Fight More
Abbott, Teva Reach Deal That Delays Generic TriCor More
Abbott and Teva: Pay-To-Delay Or Legitimate Settlement? More
How a Decades-Old Drug Is Still a Patented Blockbuster More
Pfizer, Spanning the Globe to Defend Lipitor Patents More
Reimportation
Drug Reimportation Emerges Again In Health Debate More
Drug Imports from Canada Would Be Legal Under Senate Proposal More
Advertising and Marketing
Balancing Act: Regulating Rx Marketing to Kids on the Web More
Transcripts of FDA's November 2009 Public Hearing on Social Media Available More
CBO Report: Promotional Spending for Prescription Drugs More
CBO Report Shows Hundreds Of Millions Spent On DTC Marketing More
Pharma Spending On Detailing Up More
How the Drug Industry Spends $20 Billion a Year On Marketing More
Marketing Drugs to Consumers More
New Jersey Tackles Industry Marketing to Doctors More
Court Agrees Whistleblower Suit Should Be Tossed More
Drug Reps or DTC? More
More Bad News for Pharma Reps? More
Time for Broader Study of DTC's Effectiveness More
Pharma Watch
Zetia's Miraculous Popularity More
Lipitor & the Era of Mega-Blockbusters More
Pfizer's Jeff Kindler On Corporate Trust More
GSK Shops Around for $3B Worth Acquisitions  More
NJ Governor Elect Taps Pfizer Exec As Chief Of Staff More
Report Sees Huge Pharma Tax Hike Over Next Decade More
White House Regulars: Health Insurance, Pharma, Unions More
Can Drug & Device Makers Innovate Themselves to Extinction? More
PBM Watch
CVS Faces Scrutiny in $1 Billion Texas Contract Bid More
CVS-Caremark Healthcare Merger May Put Patients at Risk More
Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries More
Michigan Saves Money by Reform More
Pharmacists Could Play Important Role In Reform More
Moody's Lowers CVS Caremark's Outlook More
Medco Beats, Provides Strong Outlook More
Strengthening The Senate Bill To Fully Protect Competition More
Medicare and Medicaid
Medicare Prescription Drug Plan Premiums To Average 11 Percent Rise in 2010 More
'Doughnut hole' Unites Seniors Wary of Health Bill More
Op-ED: Medicare Part D 'Reforms' Will Harm Seniors More
Seniors Often Reluctant To Switch Medicare Drug Plans More
Safety and Clinical Trials
Study: Consumers Ignore Lengthy Drug Safety Information More
Solvay Ruling Could Prevent Whistleblower Suits More
Zyprexa, Seroquel Expanded to Teenagers More
Further Study Of Antipsychotic Effects On Kids: FDA More
Antipsychotics, Diabetes & Kids More
Drugmakers, FDA Seek to Curb Painkiller Abuse More
FDA Issues Serious Warning For Abbott's Depakote More
FDA Urged To Ban Abbott's Meridia Diet Pill More
FDA Warning Letters Target Illegal Online Pharmacies More
Glaxo Sued Over Zinc Levels In Poligrip Adhesive More
Pfizer Faces $103 Million in Prempro Damages More
Electronic Records
VA, Kaiser Plan to Link Electronic Medical Records More
Report: Health Strategy Could Save West Virginia $1 Billion More
Privacy
Health Net Data Loss Second Major Insurer Breach of 2009 More
Searchable Database of Patient Records to Go Commercial More
Patient Identity Theft Has Grown During Recession More
Unintended Consequences: Insurance Processes Abrogates Confidentiality More
Foreign Countries
Turkey Cuts 2010 Drug Bill; Pharmacies to Protest More
Japan Will Reduce Drug Prices Next Year to Cut Costs More
Astra Zeneca to Outsource API-Making to Asia More
In Memoriam
Garis Led Drug Price Research More